Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000235255 | SCV000293098 | pathogenic | not provided | 2015-08-25 | criteria provided, single submitter | clinical testing | The A1632E missense variant in the SCN9A gene has been reported previously as a de novo variant in a patient with characteristics of both inherited erythromelalgia (IEM) and paroxysmal extreme pain disorder (PEPD) (Estacion et al., 2008). Functional analysis shows that A1632E alters channel function and results in neuronal hyperexciability (Estacion et al., 2008). The A1632E variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. It is a non-conservative amino acid substitution that occurs at a highly conserved position in between the S4 and S5 transmembrane segments of the forth homologous domain. |
Center of Genomic medicine, |
RCV000500437 | SCV000598128 | pathogenic | Paroxysmal extreme pain disorder | 2017-02-13 | criteria provided, single submitter | clinical testing | |
Department of Neurology and Geriatrics, |
RCV000500437 | SCV002549902 | pathogenic | Paroxysmal extreme pain disorder | 2021-11-16 | no assertion criteria provided | research |